Wellington Management Group LLP Acquires 103,044 Shares of The Cooper Companies, Inc. $COO

Key Points

• Wellington Management increased its Cooper Companies stake by 3.1%, acquiring 103,044 additional shares and bringing its holdings to 3.47 million shares worth approximately $248.8 million, or 1.78% of the company.
• Cooper Companies reported quarterly EPS of $1.21, beating estimates by $0.11, while revenue reached $1.08 billion and rose 7.9% year over year. Management issued fiscal 2026 EPS guidance of $4.58–$4.66.
• COO shares opened at $71.17, below the analyst consensus price target of $81.64. Analyst sentiment is mixed, with ratings ranging from Strong Buy to Sell and an overall consensus rating of Hold.

Wellington Management Group LLP increased its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 3.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,468,951 shares of the medical device company's stock after acquiring an additional 103,044 shares during the period. Wellington Management Group LLP owned approximately 1.78% of Cooper Companies worth $248,758,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Root Financial Partners LLC raised its holdings in Cooper Companies by 104.5% during the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company's stock valued at $26,000 after buying an additional 162 shares during the period. Avalon Trust Co purchased a new position in Cooper Companies during the second quarter worth $25,000. SJS Investment Consulting Inc. boosted its stake in Cooper Companies by 107.5% during the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company's stock worth $26,000 after buying an additional 187 shares during the period. Elevation Wealth Partners LLC increased its position in Cooper Companies by 1,136.4% during the second quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company's stock valued at $29,000 after acquiring an additional 375 shares during the last quarter. Finally, J.Safra Asset Management Corp bought a new position in Cooper Companies during the second quarter valued at $32,000. 24.39% of the stock is owned by institutional investors.

Cooper Companies Stock Performance

Shares of NASDAQ COO opened at $71.17 on Monday. The Cooper Companies, Inc. has a twelve month low of $58.89 and a twelve month high of $89.83. The firm has a market cap of $13.88 billion, a PE ratio of 60.31, a price-to-earnings-growth ratio of 1.86 and a beta of 0.83. The business has a fifty day simple moving average of $72.56 and a two-hundred day simple moving average of $70.81. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.10 by $0.11. The business had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business's revenue was up 7.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Analysts expect that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on COO shares. BNP Paribas Exane lowered their target price on shares of Cooper Companies from $95.00 to $92.00 and set an "outperform" rating for the company in a report on Monday, June 8th. Citigroup reiterated a "neutral" rating and set a $80.00 price target (up from $76.00) on shares of Cooper Companies in a report on Thursday, August 13th. Wells Fargo & Company reissued a "sell" rating and issued a $66.00 price objective (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. Stifel Nicolaus decreased their price objective on shares of Cooper Companies from $95.00 to $85.00 and set a "buy" rating for the company in a research note on Friday, June 5th. Finally, Piper Sandler set a $86.00 target price on Cooper Companies and gave the company an "overweight" rating in a research report on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have given a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $81.64.

Cooper Companies Profile

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source